Lymphatic Filariasis

Description

Lymphatic filariasis is caused primarily by adult worms (filariae) that live in the lymphatic vessels. The female worms release microfilariae that circulate in the peripheral blood and are ingested by mosquitoes; thus, infected mosquitoes transmit the infection from person to person. The two major species of filariae that cause lymphatic disease in humans are Wuchereria bancrofti and Brugia malayi.

Occurrence

Lymphatic filariasis affects an estimated 120 million persons in tropical areas of the world, including sub-Saharan Africa, Egypt, southern Asia, the western Pacific islands, the northeastern coast of Brazil, Guyana, and the Caribbean island of Hispaniola.

Risk for Travellers

Short-term travellers to endemic areas are at low risk for this infection. Travellers who visit endemic areas for extended periods of time and who are intensively exposed to infected mosquitoes can become infected. Most infections seen in the United States are in immigrants from endemic countries.

Clinical Presentation

Most infections are asymptomatic, but the living adult worm causes progressive lymphatic vessel dilation and dysfunction. Lymphatic dysfunction may lead to lymphoedema of the leg, scrotum, penis, arm, or breast, which can increase in severity as a result of recurrent secondary bacterial infections. Tropical pulmonary eosinophilia is a potentially serious progressive lung disease with nocturnal cough, wheezing, and fever, resulting from immune hyperresponsiveness to microfilariae in the pulmonary capillaries.

Prevention

No vaccine is available, nor has the effectiveness of chemoprophylaxis been well documented. Protective measures include avoidance of mosquito bites through the use of personal protection measures (see Protection against Mosquitoes and Other Arthropods).

Treatment

The drug of choice for treatment of travellers with W. bancrofti or B. malayi infections is diethylcarbamazine (DEC). DEC, which is available to U.S.-licensed physicians for this purpose, can be obtained from the CDC Parasitic Diseases Drug Service at 404-639-3670. (See Immunobiologics Distributed by the Centers for Disease Control and Prevention website which is available at: http://www.cdc.gov/ncidod/srp/drugs/drug-service.html.) DEC kills circulating microfilariae and is partially effective against the adult worms and tropical pulmonary eosinophilia. Many patients with lymphoedema are no longer infected with the filarial parasite and do not benefit from antifilarial drug treatment. For chronic manifestations of lymphatic filariasis, such as lymphoedema and hydrocoele, specific lymphoedema treatment (including hygiene, skin care, physical therapy, and in some cases, antibiotics) and surgical repair, respectively, are recommended. To ensure correct diagnosis and treatment, travellers should be advised to consult an infectious disease or tropical medicine specialist.

Bibliography
  • Dreyer G, Addiss D, Dreyer P, Noroes J. Basic lymphooedema management: Treatment and prevention of problems associated with lymphatic filariasis. Hollis, NH: Hollis Publishing Co.; 2002.
  • Dreyer G, Addiss D, Roberts J, Noroes J. Progression of lymphatic vessel dilatation in the presence of living adult Wuchereria bancrofti. Trans R Soc Trop Med Hyg. 2002; 96:157-61.
  • Dreyer G, Medeiros Z, Netto MJ, Leal NC, de Castro LG, Piessens WF. Acute attacks in the extremities of persons living in an area endemic for bancroftian filariasis: differentiation of two syndromes. Trans R Soc Trop Med Hyg. 1999;93:413-7.
  • Michael E, Bundy DAP, Grenfell BT. Re-assessing the global prevalence and distribution of lymphatic filariasis. Parasitology. 1996;112:409-28.
  • Ottesen, EA. Efficacy of diethylcarbamazine in eradicating infection with lymphatic-dwelling filariae in humans. Rev Infect Dis. 1985;7:341-56.
  • Shenoy RK, Suma TK, Rajan K, Kumaraswami V. Prevention of acute adenolymphangitis in brugian filariasis: comparison of the efficacy of ivermectin and diethylcarbamazine, each combined with local treatment of the affected limb. Ann Trop Med Parasitol. 1998;92:587-94.
  • Weil GJ, Lammie PJ, Weiss N. The ICT filariasis test: a rapid format antigen test for diagnosis of bancroftian filariasis. Parasitol Today. 1997;13:401-4.

- David Addiss

© Medic8 ® All Rights Reserved.